SE9400809D0 - New use of quinoline-3-carboxamide compounds - Google Patents

New use of quinoline-3-carboxamide compounds

Info

Publication number
SE9400809D0
SE9400809D0 SE9400809A SE9400809A SE9400809D0 SE 9400809 D0 SE9400809 D0 SE 9400809D0 SE 9400809 A SE9400809 A SE 9400809A SE 9400809 A SE9400809 A SE 9400809A SE 9400809 D0 SE9400809 D0 SE 9400809D0
Authority
SE
Sweden
Prior art keywords
pct
quinoline
inflammatory bowel
disease
treating inflammatory
Prior art date
Application number
SE9400809A
Other languages
English (en)
Swedish (sv)
Inventor
Agneta Svedberg
Per Gjoerstrup
Bo Nilsson
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE9400809A priority Critical patent/SE9400809D0/xx
Publication of SE9400809D0 publication Critical patent/SE9400809D0/xx
Priority to IL11290895A priority patent/IL112908A0/xx
Priority to CA002185136A priority patent/CA2185136A1/en
Priority to EP95913457A priority patent/EP0751772A1/en
Priority to JP7523403A priority patent/JPH09510198A/ja
Priority to EE9600160A priority patent/EE9600160A/et
Priority to US08/704,588 priority patent/US5728713A/en
Priority to AU20886/95A priority patent/AU690661B2/en
Priority to PCT/SE1995/000244 priority patent/WO1995024195A1/en
Priority to KR1019960704978A priority patent/KR970701545A/ko
Priority to ZA951967A priority patent/ZA951967B/xx
Priority to FI963532A priority patent/FI963532A/fi
Priority to NO963764A priority patent/NO963764L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE9400809A 1994-03-10 1994-03-10 New use of quinoline-3-carboxamide compounds SE9400809D0 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE9400809A SE9400809D0 (sv) 1994-03-10 1994-03-10 New use of quinoline-3-carboxamide compounds
IL11290895A IL112908A0 (en) 1994-03-10 1995-03-07 Pharmaceutical compositions containing quinoline-3-carboxamide compounds
KR1019960704978A KR970701545A (ko) 1994-03-10 1995-03-08 퀴놀린-3-카르복사미드 화합물의 새로운 용도(new use of quinoline-3-carboxamide compounds)
JP7523403A JPH09510198A (ja) 1994-03-10 1995-03-08 キノリン−３−カルボキシアミド化合物の新規な使用
EP95913457A EP0751772A1 (en) 1994-03-10 1995-03-08 New use of quinoline-3-carboxamide compounds
CA002185136A CA2185136A1 (en) 1994-03-10 1995-03-08 New use of quinoline-3-carboxamide compounds
EE9600160A EE9600160A (et) 1994-03-10 1995-03-08 Kinoliin-3-karboksamiidi ühendite kasutamine uuel otstarbel
US08/704,588 US5728713A (en) 1994-03-10 1995-03-08 Use of quinoline-3-carboxamide compounds
AU20886/95A AU690661B2 (en) 1994-03-10 1995-03-08 New use of quinoline-3-carboxamide compounds
PCT/SE1995/000244 WO1995024195A1 (en) 1994-03-10 1995-03-08 New use of quinoline-3-carboxamide compounds
ZA951967A ZA951967B (en) 1994-03-10 1995-03-09 Use of Quinoline-3-carboxamide compounds
FI963532A FI963532A (fi) 1994-03-10 1996-09-09 Kinoliini-3-karboksamidiyhdisteiden uusi käyttö
NO963764A NO963764L (no) 1994-03-10 1996-09-09 Ny anvendelse av kinolin-3-karboksamidforbindelser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9400809A SE9400809D0 (sv) 1994-03-10 1994-03-10 New use of quinoline-3-carboxamide compounds

Publications (1)

Publication Number Publication Date
SE9400809D0 true SE9400809D0 (sv) 1994-03-10

Family

ID=20393229

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9400809A SE9400809D0 (sv) 1994-03-10 1994-03-10 New use of quinoline-3-carboxamide compounds

Country Status (11)

Country Link
US (1) US5728713A (et)
EP (1) EP0751772A1 (et)
JP (1) JPH09510198A (et)
KR (1) KR970701545A (et)
AU (1) AU690661B2 (et)
CA (1) CA2185136A1 (et)
EE (1) EE9600160A (et)
FI (1) FI963532A (et)
SE (1) SE9400809D0 (et)
WO (1) WO1995024195A1 (et)
ZA (1) ZA951967B (et)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077850A (en) * 1997-04-21 2000-06-20 G.D. Searle & Co. Substituted benzopyran analogs for the treatment of inflammation
US6077851A (en) * 1998-04-27 2000-06-20 Active Biotech Ab Quinoline derivatives
SE9802549D0 (sv) * 1998-07-15 1998-07-15 Active Biotech Ab Quinoline derivatives
US6133285A (en) * 1998-07-15 2000-10-17 Active Biotech Ab Quinoline derivatives
SE9802550D0 (sv) * 1998-07-15 1998-07-15 Active Biotech Ab Quinoline derivatives
US6121287A (en) * 1998-07-15 2000-09-19 Active Biotech Ab Quinoline derivatives
PT2609086E (pt) * 2010-08-27 2015-06-30 Gruenenthal Gmbh 2-oxo- e 2-tioxo-di-hidroquinolina-3-carboxamidas substituídas como moduladores de kcnq2/3
EP2627638B1 (en) 2010-10-14 2017-07-12 Immunahr AB 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators.
GB202006390D0 (en) * 2020-04-30 2020-06-17 Aqilion Ab Novel treatments

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1034124A (en) * 1973-05-11 1978-07-04 Ciba-Geigy Ag Process for the manufacture of new quinolines
FR2340735A1 (fr) * 1976-02-11 1977-09-09 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
IE52670B1 (en) * 1981-03-03 1988-01-20 Leo Ab Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
US5084575A (en) * 1987-07-31 1992-01-28 American Home Products Corporation Quinoline substituted naphthalenepropionic acid derivatives as anti-inflammatory/antiallergic agents
US5310913A (en) * 1989-06-09 1994-05-10 Kabi Pharmacia Aktiebolag Derivatives of quinoline-3-carboxanilide
SE8902076D0 (sv) * 1989-06-09 1989-06-09 Pharmacia Ab Derivatives of quinoline-3-carboxanilide
SE9000624D0 (sv) * 1990-02-22 1990-02-22 Pharmacia Ab New use
SE9001111D0 (sv) * 1990-03-27 1990-03-27 Pharmacia Ab Supportive use
US5202338A (en) * 1990-10-31 1993-04-13 Vilmos Bar Dihydroquinoline derivatives, pharmaceutical compositions and methods of use of dihydroquinoline derivatives as modulators of the arachidonic acid cascade
AU1583392A (en) * 1991-03-13 1992-10-21 Smithkline Beecham Corporation Leukotriene antagonists
SE469368B (sv) * 1991-10-09 1993-06-28 Kabi Pharmacia Ab Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms)

Also Published As

Publication number Publication date
FI963532A (fi) 1996-11-06
WO1995024195A1 (en) 1995-09-14
US5728713A (en) 1998-03-17
JPH09510198A (ja) 1997-10-14
EE9600160A (et) 1997-06-16
KR970701545A (ko) 1997-04-12
FI963532A0 (fi) 1996-09-09
ZA951967B (en) 1995-12-11
EP0751772A1 (en) 1997-01-08
AU690661B2 (en) 1998-04-30
AU2088695A (en) 1995-09-25
CA2185136A1 (en) 1995-09-14

Similar Documents

Publication Publication Date Title
SE9302490D0 (sv) New use of old drugs
ATE213727T1 (de) In position 3 durch eine stickstoffgruppe substituierte 1,3-dihydroindol-2-on derivate als vasopressin und/oder ocytocin agonisten und/oder antagonisten
EA199700117A1 (ru) Трициклические бензазепиновые антагонисты вазопрессина, способ их получения, фармацевтическая композиция и способ лечения млекопитающих с использованием трициклических бензазепинов
HK1021699A1 (en) Pentafluorobenzenesulfonamides and analogs.
ES8403897A1 (es) Procedimiento para la fabricacion de nuevos derivados de la amino-3 quinuclidina
DE69816091D1 (de) Indol-derivate und ihre anwendung als mcp-1 antagonisten
YU1501A (sh) Derivati hinolina
DE69329727D1 (de) Neue imidazol derivate, ihre herstellung und therapeutische verwendung
TR200103525T2 (tr) Bisiklik poliaminosit metal kompleksleri, bunları hazırlamak için yöntem ve bunların tıbbi görüntülemede kullanımı.
ATE305007T1 (de) Stickstoffhaltige heterocyclische verbindungen, ihre herstellung und verwendung
GR3033528T3 (en) Novel piperidine derivatives with paf antagonist activity
SE9400809D0 (sv) New use of quinoline-3-carboxamide compounds
SE9102909D0 (sv) New use
NO951484L (no) Kinolon- og akridinon-derivater for behandling av urininkontinens
EA200500882A1 (ru) N-арилсульфонил-3-аминоалкоксииндолы
ATE269865T1 (de) Pyrazolo(3,4-g)chinoxaline als pdgf-rezeptor protein tyrosin-kinase inhibitoren
SE9400810D0 (sv) New use of Quinoline-3-carboxamide compounds
ES2069892T3 (es) Complejos de ciclopentadienilcarbonilo-99mtc, procedimiento para su preparacion asi como su utilizacion en el diagnostico.
CA2131831A1 (en) The use of quinoline-3-carboxamide compounds for treatment of diabetes
NZ504124A (en) Phenyl-alkyl-imidazoles and use in treating inflammatory disease
PH31442A (en) New chromene derivative compounds.
KR960705791A (ko) 기억력 향상제로서 유용한 3-아릴-4-알킬 및 4,5-디알킬-4H-1,2,4-트리아졸(3Aryl-4-alkyl and 4,5-dialkyl-4H-1,2,4-triazoles useful as memory enhancers)
TR199701604T2 (xx) Pirol t�revleri i�in yeni ba�vuru
NO963764L (no) Ny anvendelse av kinolin-3-karboksamidforbindelser
RU96119975A (ru) Новое применение соединений хинолин-3-карбоксамида